At Verified Market Intelligence, we provide a market study that encompasses both qualitative and quantitative assessments of latest trends for the market segmentations classified by our analysts. According to our research team, the Global In Vitro Diagnostics (IVD) Quality Control Market was valued at USD 840.1 million in 2017 and is projected to reach USD 1,077.6 million by 2025, growing at a CAGR of 3.2% from 2018 to 2025. Our research study mainly includes an in-depth study of the market which includes major drivers, restraints, opportunities and challenges faced in the market along with the latest industrial trends.
In vitro studies can be described as set of experiments performed to detect the presence of microorganisms which can cause pathogenesis in the host. In vitro diagnostics (IVD) quality control is of prime concern to the clinicians as well as customers so as to have a check on the quality of the diagnostic tests performed.
It has been observed that customers are highly inclined in getting themselves checked every year due to growing number of diseases. This gives rise to establishment of more number of diagnostics laboratories worldwide along with third party quality control products. These characteristics of the global In Vitro Diagnostics (IVD) quality control market has been driving the market. Apart from this, high costs of quality control products might hamper the growth of overall market at a global status.
The "Global In Vitro Diagnostics (IVD) Quality Control Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Bio-Rad Laboratories, Inc., Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Helena Laboratories, Ortho Clinical Diagnostics, SERO AS, Siemens Healthineers, Sun Diagnostics and Roche Diagnostics. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
As a part of market estimation, the study also comprises a list of tables and figures for the "Global In Vitro Diagnostics (IVD) Quality Control Market" which focuses on a constructive knowledge essential for the companies or individuals interested in the market study report. As a part of market segmentation, our study exhibits a market analysis on the basis of product, application, end user and geography.
On the basis of product, the "Global In Vitro Diagnostics (IVD) Quality Control Market" can be divided into serum/plasma based, whole blood based and urine based. The market analytics also comprises of a segmentation on the basis of end users which typically includes hospitals, clinics and research and academics. In terms of geography, Asia Pacific accounts for the fastest growing market due to the presence of numerous developing countries in this region along with their emerging markets. The Chinese market has a major share in this region.
Table of Contents
Chapter 1 INTRODUCTION OF GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET 15
1.1 Market Overview 15
1.2 Market Segmentation 16
1.3 Assumptions 17
Chapter 2 EXECUTIVE SUMMARY 18
2.1 Overview of the Market 18
2.2 Global In Vitro Diagnostics (IVD) Quality Control Market, By Product - 2016 (USD Million) 19
2.3 Global In Vitro Diagnostics (IVD) Quality Control Market, By Application - 2016 (USD Million) 20
2.4 Global Pemetrexed Acid Market, By Geography (CAGR% 2017-2025) 21
Chapter 3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE 22
3.1 Data Mining 22
3.2 Secondary Research 22
3.3 Primary Research: 22
3.4 Subject Matter Expert Advice: 23
3.5 Quality Check 23
3.6 Final Review 23
3.7 Validation 24
3.8 Primary Interviews 24
3.9 Research Scope and Assumptions 25
3.10 List of data sources 25
Chapter 4 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET OUTLOOK 27
4.1 Market Dynamics 27
4.1.1 Market Drivers 28
4.1.2 Rise in number of Pathology labs in developing countries 28
4.1.3 Increment in the use of third party QC products 29
4.1.4 Market Restraints 31
4.1.5 Risks in reimbursement from IVD centers 31
4.1.6 High Cost of Quality Control 32
4.2 Porter's Five Force Analysis 33
4.3 Regulatory Framework 34
4.3.1 Europe 34
4.3.2 U.S. (FDA) 37
Chapter 5 GLOBALIN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT 40
5.1 Overview 41
5.2 Serum/Plasma-based Products 42
5.3 Whole Blood Based Products 43
5.4 Urine Based Products 44
5.5 Other Products 45
Chapter 6 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION 47
6.1 Overview 48
6.2 Immunochemistry 50
6.3 Clinical Chemistry 51
6.4 Hematology 52
6.5 Molecular Diagnostics 53
6.6 Coagulation/Hemastosis 54
6.7 Microbiology 55
6.8 Others 56
Chapter 7 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER 57
7.1 Overview 58
7.2 Hospitals 60
7.3 Clinical laboratories 61
7.4 Research and Academic Institutes 62
7.5 Others 63
Chapter 8 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY GEOGRAPHY 64
8.1 Overview 65
8.2 North America 68
8.2.1 U.S. 73
8.2.2 Canada 76
8.2.3 Mexico 79
8.3 Europe 82
8.3.1 Germany 87
8.3.2 UK 90
8.3.3 France 93
8.3.4 Rest of Europe 96
8.4 Asia Pacific 99
8.4.1 China 104
8.4.2 Japan 107
8.4.3 India 110
8.4.4 Rest of Asia Pacific 113
8.5 Latin America 116
8.5.1 Brazil 121
8.5.2 Rest of Latin America 124
8.6 Middle East and Africa 127
Chapter 9 COMPETITIVE LANDSCAPE 130
9.1 Company Market Share 130
9.2 Key Trends 131
Chapter 10 COMPANY PROFILES 133
10.1 Bio-Rad Laboratories, Inc. 133
10.1.1 Company Overview 133
10.1.2 Bio-Rad Laboratories, Inc.: Key Facts 133
10.1.3 Financial Performance 134
10.1.4 Product Benchmarking 135
10.2 Abbott Laboratories Inc 142
10.2.1 Company Overview 142
10.2.2 Abbott Laboratories Inc: Key Facts 142
10.2.3 Financial Performance 143
10.2.4 Product Benchmarking 144
10.3 Thermo Fisher Scientific Inc. 145
10.3.1 Company Overview 145
10.3.2 Thermo Fisher Scientific Inc.: Key Facts 145
10.3.3 Financial Performance 146
10.3.4 Product Benchmarking 147
10.4 Helena Laboratories 149
10.4.1 Company Overview 149
10.4.2 Helena Laboratories: Key Facts 149
10.4.3 Product Benchmarking 150
10.5 SeraCare Life Sciences, Inc. 151
10.5.1 Company Overview 151
10.5.2 SeraCare Life Sciences, Inc.: Key Facts 151
10.5.3 Product Benchmarking 151
10.6 Ortho Clinical Diagnostics, Inc. 152
10.6.1 Company Overview 152
10.6.2 ITW Linx, Surge Protection: Key Facts 152
10.6.3 Product Benchmarking 153
10.7 Sun Diagnostics, LLC 154
10.7.1 Company overview 154
10.7.2 Sun Diagnostics, LLC: Key Facts 154
10.7.3 Product Benchmarking 155
10.8 SERO AS 156
10.8.1 Company Overview 156
10.8.2 SERO AS: Key Facts 156
10.8.3 Product Benchmarking 157
10.9 Randox Laboratories Ltd. 158
10.9.1 Company Overview 158
10.9.2 Randox Laboratories Ltd.: Key Facts 158
10.9.3 Product Benchmarking 159
10.10 Siemens Healthineers 160
10.10.1 Company Overview 160
10.10.2 Siemens Healthineers: Key Facts 160
10.10.3 Financial Performance 161
10.10.4 Product Benchmarking 162
10.11 Technopath Clinical Diagnostics 164
10.11.1 Company Overview 164
10.11.2 Technopath Clinical Diagnostics: Key Facts 164
10.11.3 Product Benchmarking 165
10.12 Roche Diagnostics 167
10.12.1 Company Overview 167
10.12.2 Roche Diagnostics: Key Facts 167
10.12.3 Financial Performance 168
10.12.4 Product Benchmarking 169
List of Tables
TABLE 1 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 42
TABLE 2 GLOBAL PEMETRXED DIACID MARKET, BY CANCER TYPE, 2012 - 2025 (USD MILLION) 49
TABLE 3 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 59
TABLE 4 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY GEOGRAPHY, 2012 - 2025 (USD MILLION) 67
TABLE 5 NORTH AMERICAIN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY COUNTRY, 2012 - 2025 (USD MILLION) 69
TABLE 6 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 70
TABLE 7 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 71
TABLE 8 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 72
TABLE 9 U.S. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 73
TABLE 10 U.S. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 74
TABLE 11 U.S. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 75
TABLE 13 CANADA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 76
TABLE 14 CANADA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 77
TABLE 15 CANADA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 78
TABLE 16 MEXICO IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 79
TABLE 17 MEXICO IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 80
TABLE 18 MEXICO IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 81
TABLE 19 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROLMARKET, BY COUNTRY, 2012 - 2025 (USD MILLION) 83
TABLE 20 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 84
TABLE 21 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 85
TABLE 22 EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 86
TABLE 23 GERMANY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 87
TABLE 24 GERMANY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 88
TABLE 25 GERMANY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 89
TABLE 26 UK IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 90
TABLE 27 UK IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 91
TABLE 28 UK IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 92
TABLE 29 FRANCE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 93
TABLE 30 FRANCE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 94
TABLE 31 FRANCE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 95
TABLE 32 REST OF EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 96
TABLE 33 REST OF EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 97
TABLE 34 REST OF EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 98
TABLE 35 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY COUNTRY, 2012 - 2025 (USD MILLION) 100
TABLE 36 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 101
TABLE 37 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 102
TABLE 38 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 103
TABLE 39 CHINA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 104
TABLE 40 CHINA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 105
TABLE 41 CHINA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 106
TABLE 42 JAPAN IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 107
TABLE 43 JAPAN IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 108
TABLE 44 JAPAN IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 109
TABLE 45 INDIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 110
TABLE 46 INDIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 111
TABLE 47 INDIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 112
TABLE 48 REST OF ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 113
TABLE 49 REST OF ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 114
TABLE 50 REST OF ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 115
TABLE 51 LATIN AMERICAIN VITRO DIAGNOSTICS (IVD) QUALITY CONTROLMARKET, BY COUNTRY, 2012 - 2025 (USD MILLION) 117
TABLE 52 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 118
TABLE 53 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 119
TABLE 54 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 120
TABLE 55 BRAZIL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 121
TABLE 56 BRAZIL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 122
TABLE 57 BRAZIL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 123
TABLE 58 REST OF LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 124
TABLE 59 REST OF LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 125
TABLE 60 REST OF LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 126
TABLE 61 MIDDLE EAST AND AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT, 2012 - 2025 (USD MILLION) 127
TABLE 62 MIDDLE EAST AND AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2012 - 2025 (USD MILLION) 128
TABLE 63 MIDDLE EAST AND AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2012 - 2025 (USD MILLION) 129
List of Figures
FIG. 1 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SEGMENTATION 16
FIG. 2 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET OVERVIEW 18
FIG. 3 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT - 2016 (USD MILLION) 19
FIG. 4 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION - 2016 (USD MILLION) 20
FIG. 5 GLOBAL PEMETREXED ACID MARKET, BY GEOGRAPHY (CAGR% 2017-2025) 21
FIG. 6 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET OUTLOOK 27
FIG. 7 A COMPARISON OF EMS REVENUE SEGMENTATION IN 2008 AND 2016 (PROJECTED) 30
FIG. 8 IN VITRO DIAGNOSTICS QUALITY CONTROL MARKET - PORTER'S ANALYSIS 33
FIG. 9 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SHARE, BY PRODUCT, 2016 (%) 41
FIG. 10 GLOBAL SERUM/PLASMA BASED PRODUCTS MARKET REVENUE IN IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 43
FIG. 11 GLOBAL WHOLE BLOOD BASED PRODUCTS MARKET REVENUE IN IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 44
FIG. 12 GLOBAL WHOLE BLOOD BASED PRODUCTS MARKET REVENUE IN IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 45
FIG. 13 GLOBAL OTHER QUALITY CONTROL PRODUCTS MARKET REVENUE IN IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 46
FIG. 14 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SHARE, BY APPLICATION 48
FIG. 15 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN IMMUNOCHEMISTRY, 2012 - 2025 (USD MILLION) 50
FIG. 16 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN CLINICAL CHEMISTRY, 2012 - 2025 (USD MILLION) 51
FIG. 17 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN HEMATOLOGY, 2012 - 2025 (USD MILLION) 52
FIG. 18 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN MOLECULAR DIAGNOSTICS, 2012 - 2025 (USD MILLION) 53
FIG. 19 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN COAGULATION/HEMASTOSIS, 2012 - 2025 (USD MILLION) 54
FIG. 20 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN MICROBIOLOGY, 2012 - 2025 (USD MILLION) 55
FIG. 21 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN OTHER APPLICATIONS, 2012 - 2025 (USD MILLION) 56
FIG. 22 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET SHARE, BY END USER, 2016 (%) 58
FIG. 23 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN HOSPITALS, 2012 - 2025 (USD MILLION) 60
FIG. 24 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN CLINICAL LABORATORIES, 2012 - 2025 (USD MILLION) 61
FIG. 25 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN RESEARCH AND ACADEMIC INSTITUTES, 2012 - 2025 (USD MILLION) 62
FIG. 26 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET DEMAND IN OTHER END USERS, 2012 - 2025 (USD MILLION) 63
FIG. 27 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY GEOGRAPHY, 2012 - 2025 66
FIG. 28 NORTH AMERICA MARKET SNAPSHOT 68
FIG. 29 NORTH AMERICAIN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY COUNTRY, 2016 69
FIG. 30 U.S. IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 73
FIG. 31 CANADA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 76
FIG. 32 MEXICO IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROLMARKET, 2012 - 2025 (USD MILLION) 79
FIG. 33 EUROPE MARKET SNAPSHOT 82
FIG. 34 EUROPEIN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY COUNTRY, 2016 83
FIG. 35 GERMANY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL, 2012 - 2025 (USD MILLION) 87
FIG. 36 UK IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 90
FIG. 37 FRANCE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 93
FIG. 38 REST OF EUROPE IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 96
FIG. 39 ASIA PACIFIC MARKET SNAPSHOT 99
FIG. 40 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY COUNTRY, 2016 100
FIG. 41 CHINA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 104
FIG. 42 JAPAN IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 107
FIG. 43 INDIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 110
FIG. 44 REST OF ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 113
FIG. 45 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY COUNTRY, 2016 117
FIG. 46 BRAZIL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 121
FIG. 47 REST OF LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 124
FIG. 48 MIDDLE EAST AND AFRICA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, 2012 - 2025 (USD MILLION) 127
FIG. 49 IN VITRO DIAGNOSTICS QUALITY CONTROL COMPANY MARKET SHARES 130
FIG. 50 BIO-RAD LABORATORIES, INC. FINANCIAL PERFORMANCE: REVENUE, 2014 - 2016 (USD MILLION) 134
FIG. 51 BIO-RAD LABORATORIES, INC. FINANCIAL PERFORMANCE, BY REGION (% REVENUE, 2016) 135
FIG. 52 ABBOTT LABORATORIES INC FINANCIAL PERFORMANCE: REVENUE, 2014 - 2016 (USD MILLION) 143
FIG. 53 THERMO FISHER SCIENTIFIC INC FINANCIAL PERFORMANCE: REVENUE, 2014 - 2016 (USD MILLION) 146
FIG. 54 THERMO FISHER SCIENTIFIC INC FINANCIAL PERFORMANCE, BY REGION (% REVENUE, 2016) 147
FIG. 55 SIEMENS HEALTHINEERS FINANCIAL PERFORMANCE: REVENUE, 2014 - 2016 (USD MILLION) 161
FIG. 56 SIEMENS HEALTHINEERSFINANCIAL PERFORMANCE, BY REGION (% REVENUE, 2016) 162
FIG. 57 ROCHE DIAGNOSTICS FINANCIAL PERFORMANCE: REVENUE, 2014 - 2016 (USD MILLION) 168
FIG. 58 ROCHE DIAGNOSTICS FINANCIAL PERFORMANCE, BY REGION (% REVENUE, 2016) 169
The Digital Experience Orchestration (DXO) Platforms Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competiti...
The Intelligent Scenic Spot Guide System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Prefabricated Construction Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Clinical Trial Simulation Tools Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Small Molecule Drug Design Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Reagent Inventory Management Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Embodied Intelligent Simulation Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Subsea Cable Moulding Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Virtual Live Streaming Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Meeting Room Display Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...